Anemed LLC is structured around development of a novel non-invasive oral appliance having perhaps significant potential effectively to tackle and to treat, Obstructive Sleep Apnea (OSA) -- a serious condition that affects an estimated 4% of the US population. During sleep, the tongue can fall into the oropharynx and occlude the airways, Patients with this condition suffer many instances of apneas (complete cessation of breathing) and hypopneas (period of abnormally low respiratory rate).
